ArticleJournal of gastroenterology2023

Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study.

Le Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.